Volume 8, Number 2—February 2002
Research
Clinical Significance and Epidemiology of NO-1, an Unusual Bacterium Associated with Dog and Cat Bites
Table 1
Case no. | State | Gender/ age (yrs) | Animal | Wound site | No. days ill | Sutured | Major clinical features | Antibiotic treatment/outcome |
---|---|---|---|---|---|---|---|---|
1 | MA | F/22 | Cat | Hand | 8 | Unk. | Cellulitis, loss of motion, drainage, fever | Improved with cephradine + penicillin (OP) |
2 | IL | M/45 | Dog | Hand | 5 | Unk. | Purulent drainage, redness and swelling extending up to forearm | Cefadroxil (OP); next day admitted to hospital and gradual improvement with ampicillin/sulbactam (IP) |
3 | IL | F/11 | Dog | Hand | 6 | Yes | Cellulitis, discharge, local increase in temperature | Improved with ampicillin + ceftriaxone, local bacitracin (IP) |
4 | RI | F/78 | Cat | Hand | 3 | Unk. | Cellulitis, decrease movement | Antibiotic ointment + amoxicillin/clavulanic acid (OP1); penicillin (OP2); admitted to hospital next evening and gradually improved on ampicillin/sulbactam (IP) |
5 | SC | F/37 | Dog | Hand | 7 | Unk. | Cellulitis, purulent drainage | Cephradine (OP); admitted to hospital and improved on gentamicin + ampicillin (IP) |
6 | GA | M/7 | Dog | Leg | 11 | Yes | Cellulitis, profuse drainage, fever, red streaking, inguinal adentitis, chills | Amoxicillin (OP); improved on penicillin + cefazolin, changed to cephalexin (IP) |
7 | MA | M/61 | Dog | Arm | Unk. | Unk. | Superficial laceration with streaking | Penicillina (OP) |
8 | CA | M/35 | Dog | Hand | 3 | Yes | Cellulitis, loss of motion | Iproved with cefazolin + cephradine (OP) |
9 | CA | F/24 | Cat | Hand | 2 | Unk. | Cellulitis, purulent discharge, lymphadenitis, tingling sensations | Resolved with cefazolin + penicillin (IP); |
10 | TN | F/51 | Dog | Face | 5 | Yes | Pustule of wound | Improved with cephalexin (OP) |
11 | NV | F/56 | Cat | Arm | Unk. | Unk. | Swelling, lymphadenopathy | Dicloxacillina (OP) |
12 | MI | F/21 | Dog | Hand | 3 | Yes | Cellulitis, impaired range of motion | Cefaclor (OP) + improved with cefazolin (IP) |
Unk. = Unknown; OP = outpatient; OP1 = outpatient visit 1; OP2 = outpatient visit 2; IP = inpatient.
aIncomplete information on condition of infection following treatment.
Page created: July 14, 2010
Page updated: July 14, 2010
Page reviewed: July 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.